Aligos Therapeutics, Inc. - Common Stock, par value, $0.0001 per share (ALGS)

CUSIP: 01626L204

Q1 2026 13F Holders as of 31 Mar 2026

Holder snapshot 6 signals
Share change
-42,805
SEC-reported price per share
$7.43
Number of holders
34
Value change
-$479,274
Number of buys
11
Number of sells
18
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
5,646,929

Security key

01626L204

Report period

Q1 2026

Institutions

34

Top holders

10

Ownership snapshot

Top reported holders of ALGS - Aligos Therapeutics, Inc. - Common Stock, par value, $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Alyeska Investment Group,...
Disclosed value leader
Deep Track Capital, LP
Comparable rows
15/15
Latest evidence
31 Dec 2025
13F 13D/G Lead comparable stake: 10% 13D/G row: Alyeska Investment Group, L.P. Showing 1-6 of 15 holder rows.

Quick read

Alyeska Investment Group, L.P. leads the comparable SEC ownership view at 10%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Alyeska Investment Group, L.P.'s linked filing trail.
Comparable ownership Top 5
Alyeska Investment Group, L.P. 10%
Sio Capital Management, LLC 5.5%
ARMISTICE CAPITAL, LLC 5%
Woodline Partners LP 4.4%
Adage Capital Management, L.P. 3.9%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Alyeska Investment Group, L.P.
13F 13D/G
Company
10%
from 13D/G
$3,839,840
412,000 shares
31 Dec 2025
Sio Capital Management, LLC
13F 13D/G
Company
5.5%
from 13D/G
$3,130,933
335,937 shares
31 Dec 2025
ARMISTICE CAPITAL, LLC
13D/G
5%
$998,721
188,438 shares
$0 31 Dec 2024
Woodline Partners LP
13F 13D/G
Company
4.4%
from 13D/G
$2,695,055
289,169 shares
31 Dec 2025
Adage Capital Management, L.P.
13D/G
3.9%
$1,514,100
210,000 shares
-$829,150 30 Jun 2025
EcoR1 Capital, LLC
13D/G
3.9%
$1,116,360
210,634 shares
$0 31 Mar 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
34
Shares
2,775,086
Rows available
34
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2026 vs Q4 2025 Across Filers

Q4 2025 holders
39
Q1 2026 holders
34
Holder diff
-5
Investor Q4 2025 Shares Q1 2026 Shares Share Diff Share Chg % Q4 2025 value Q1 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .